These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9698078)
1. Region-specific changes in CNS muscarinic acetylcholine receptors in a rat model of hyperammonemia. Rukmini Devi RP; Murthy CR Biochem Pharmacol; 1998 Jul; 56(2):237-41. PubMed ID: 9698078 [TBL] [Abstract][Full Text] [Related]
2. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
3. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. Ehlert FJ; Tran LP J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898 [TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
5. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors. Das S; Matwyshyn GA; Bhargava HN Peptides; 1986; 7(1):21-5. PubMed ID: 2872660 [TBL] [Abstract][Full Text] [Related]
6. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
7. Selectivity of oxomemazine for the M1 muscarinic receptors. Lee SW; Woo CW; Kim JG Arch Pharm Res; 1994 Dec; 17(6):443-51. PubMed ID: 10319156 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes. Zhang LB; Horowitz B; Buxton IL Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444 [TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
10. Characterization of muscarinic acetylcholine receptors in the rat epididymis. MarĂ³stica E; Guaze EF; Avellar MC; Porto CS Biol Reprod; 2001 Oct; 65(4):1120-6. PubMed ID: 11566733 [TBL] [Abstract][Full Text] [Related]
11. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708 [TBL] [Abstract][Full Text] [Related]
15. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants. Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173 [TBL] [Abstract][Full Text] [Related]
17. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA; Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [TBL] [Abstract][Full Text] [Related]
18. Characterization of cholinergic muscarinic receptors in the rabbit iris. Honkanen RE; Abdel-Latif AA Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881 [TBL] [Abstract][Full Text] [Related]
19. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes. Vanderheyden P; Ebinger G; Vauquelin G Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439 [TBL] [Abstract][Full Text] [Related]
20. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex. Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]